Calidi Biotherapeutics Inc. (CLDI) — Financial Flexibility Index
Calidi Biotherapeutics Inc. (CLDI) has a Financial Flexibility Index of -0.98x as of December 2025. Free cash flow of $-5.01 Million (operating CF $-5.04 Million minus capex $29.00K) represents -1% of total liabilities ($5.10 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Calidi Biotherapeutics Inc. Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Calidi Biotherapeutics Inc. across 6 annual periods. See CLDI working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Calidi Biotherapeutics Inc. (2020–2025)
Year-by-year free cash flow to debt coverage for Calidi Biotherapeutics Inc.. For the full company profile including market capitalisation, see Calidi Biotherapeutics Inc. market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.15x | $-21.17 Million | $-21.29 Million | $5.10 Million | ▼ -157.8% |
| 2024 | -1.61x | $-19.68 Million | $-19.69 Million | $12.21 Million | ▼ -11.4% |
| 2023 | -1.45x | $-26.40 Million | $-26.98 Million | $18.25 Million | ▼ -499.9% |
| 2022 | -0.24x | $-12.79 Million | $-13.21 Million | $53.04 Million | ▲ +17.2% |
| 2021 | -0.29x | $-7.57 Million | $-7.77 Million | $26.00 Million | ▼ -58.3% |
| 2020 | -0.18x | $-4.47 Million | $-4.83 Million | $24.33 Million | — |